Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Dyne Therapeutics aggregated by PharmaCompass.com.

    Client Virtual Booth

    DYNE THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Dyne Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    400 Technology Square 10th Floor Cambridge, MA, 02139
    Telephone
    Telephone
    (508) 277-8117
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.dyne-tx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dynetx
    Twitter
    Twitter
    https://twitter.com/dyne_tx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium
    Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium

    https://investors.dyne-tx.com/news-releases/news-release-details/dyne-therapeutics-present-cantor-virtual-muscular-dystrophy

    PRESS RELEASE
    27 Mar 2024
    Share Share
    Dyne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    Dyne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2024/03/27/2853602/0/en/Dyne-Therapeutics-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4-to-Newly-Appointed-President-and-Chief-Executive-Officer.html

    GLOBENEWSWIRE
    27 Mar 2024
    Share Share
    Dyne Therapeutics Announces CEO Transition
    Dyne Therapeutics Announces CEO Transition

    https://www.globenewswire.com/news-release/2024/03/25/2851521/0/en/Dyne-Therapeutics-Announces-CEO-Transition.html

    GLOBENEWSWIRE
    25 Mar 2024
    Share Share
    Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
    Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days

    https://www.globenewswire.com//news-release/2024/03/13/2845320/0/en/Dyne-Therapeutics-to-Present-at-Stifel-2024-Virtual-CNS-Days.html

    GLOBENEWSWIRE
    13 Mar 2024
    Share Share
    Dyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
    Dyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

    https://www.globenewswire.com//news-release/2024/03/05/2840336/0/en/Dyne-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Recent-Business-Highlights.html

    GLOBENEWSWIRE
    05 Mar 2024
    Share Share
    Dyne Announces Presentations on Initial Data From ACHIEVE Trial in DM1 Patients
    Dyne Announces Presentations on Initial Data From ACHIEVE Trial in DM1 Patients

    https://www.globenewswire.com//news-release/2024/02/14/2829473/0/en/Dyne-Therapeutics-Announces-Upcoming-Presentations-on-Initial-Clinical-Data-From-its-ACHIEVE-Trial-in-DM1-Patients-and-DELIVER-Trial-in-DMD-Patients-at-the-2024-Muscular-Dystrophy-.html

    GLOBENEWSWIRE
    14 Feb 2024
    Share Share
    Dyne Therapeutics to Present at February Investor Conferences
    Dyne Therapeutics to Present at February Investor Conferences

    https://www.globenewswire.com//news-release/2024/02/01/2821896/0/en/Dyne-Therapeutics-to-Present-at-February-Investor-Conferences.html

    GLOBENEWSWIRE
    01 Feb 2024
    Share Share
    Dyne Therapeutics Announces Closing of Public Offering of Common Stock
    Dyne Therapeutics Announces Closing of Public Offering of Common Stock

    https://www.globenewswire.com//news-release/2024/01/11/2808324/0/en/Dyne-Therapeutics-Announces-Closing-of-Public-Offering-of-Common-Stock-and-Full-Exercise-by-Underwriters-of-Option-to-Purchase-Additional-Shares.html

    GLOBENEWSWIRE
    11 Jan 2024
    Share Share
    Dyne Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
    Dyne Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

    https://www.globenewswire.com//news-release/2024/01/05/2804579/0/en/Dyne-Therapeutics-to-Present-at-42nd-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    05 Jan 2024
    Share Share
    Dyne Announces Pricing of $300 Million Public Offering of Common Stock
    Dyne Announces Pricing of $300 Million Public Offering of Common Stock

    https://investors.dyne-tx.com/news-releases/news-release-details/dyne-therapeutics-announces-pricing-300-million-public-offering

    PRESS RELEASE
    04 Jan 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search